Create Account
Log In
Dark
chart
exchange
Premium
Terminal
Screener
Stocks
Crypto
Forex
Trends
Depth
Close
Check out our API


Celldex Therapeutics Reports Initiation Of Phase 1b Study Of CDX-0159 In Chronic Spontaneous Urticaria


Benzinga | Oct 13, 2020 08:01AM EDT

Celldex Therapeutics Reports Initiation Of Phase 1b Study Of CDX-0159 In Chronic Spontaneous Urticaria






Share
About
Pricing
Policies
Markets
API
Info
tz UTC-4
Connect with us
ChartExchange Email
ChartExchange on Discord
ChartExchange on X
ChartExchange on Reddit
ChartExchange on GitHub
ChartExchange on YouTube
© 2020 - 2026 ChartExchange LLC